Toxoplasmic encephalitis in HIV-infected persons: Risk factors and trends

AIDS

Volumn 10, Issue 12, 1996, Pages 1393-1399

  Jones, Jeffrey L ^a   Hanson, Debra L ^a   Chu, Susan Y ^a   Ciesielski, Carol A ^a   Kaplan, Jonathan E ^a   Ward, John W ^a   Navin, Thomas R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; HIV infection; Toxoplasmosis

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; SULFONAMIDE;

ADOLESCENT; ADULT; ARTICLE; ENCEPHALITIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE; TOXOPLASMOSIS; UNITED STATES;

EID: 0029780776     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199610000-00012     Document Type: Article

References (33)

1. Porter SB, Sande MA: Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992, 327:1643-1648.
2. Renold C, Sugar A, Chave JP, et al.: Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine 1992, 71:224-239.
3. USPHS/IDSA Prevention of Opportunistic Infections Working Group: USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease specific recommendations. Clin Infect Dis 1995, 21 (suppl 1):S32-S43.
4. Oksenhendler E, Charreau I, Fournerie C, Azihary M, Carbon C, Aboulker J-P: Toxoplasma gondii infection in advanced HIV infection. AIDS 1994, 8:483-487.
5. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D: Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990, 4:519-521.
6. Suzuki Y, Wong S, Grumet F, et al.: Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis 1996, 173:265-268.
7. Dubey JP: Toxoplasma, Hammondia, Besnoitia, Sarcocystis, and other tissue cyst-forming coccidia of man and animals. In Parasitic Protozoa, Vol 3. Edited by Kreier JP. New York: Academic Press Inc; 1977:101-237.
8. Frenkel JK, Ruiz A, Chinchilla M: Soil survival of Toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg 1975, 24:439-443.
9. Dubey JP: Effect of freezing on the infectivity of Toxoplasma cysts to cats. J Am Vet Med Assoc 1974, 165:534-536.
10. Benensovariedn MW, Takafuji ET, Lemon SM, Greenup RL, Sulzer AJ: Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med 1982, 307:666-669.
11. Sacks JJ, Roberto RR, Brooks NF: Toxoplasmosis infection associated with raw goats milk. JAMA 1982, 248:1728-1732.
12. Duby JP: Zoonosis updates: toxoplasmosis. J Am Vet Med Assoc 1990:123-127.
13. Ryning FW, McLeod R, Maddox JC, et al.: Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med 1979, 90:47-49.
14. Britt RH, Enzmann DR, Remington JS: Intracranial infection in cardiac transplant recipients. Ann Neurol 1981, 9:107-119.
15. Siegel SE, Lunde MN, Gelderman AH, et al.: Transmission of toxoplasmosis by leukocyte transfusion. Blood 1971, 37:388-394.
16. Kimball AC, Dean BH, Fuchs F: Toxoplasmosis: risk variations in New York City obstetric patients. Am J Obstet Gynecol 1974, 119:208-214.
17. Jacobs L, Remington JS, Melton ML: A survey of meat samples from swine, cattle, and sheep for the presence of encysted Toxoplasma. J Parasitol 1960, 46:23-28.
18. Dubey JP: A review of toxoplasmosis in pigs. Vet Parasitol 1986, 19:181-223.
19. Wallace MR, Rosetti RJ, Olson PE: Cats and toxoplasmosis risk in HIV-infected adults. JAMA 1993, 269:76-77.
20. Beaman MH, McCabe RE, Wong S, Remington JS: Toxoplasma gondii. In Principles and Practice of Infectious Diseases, 4th Edn. Edited by Mandell GL, Bennett JE, Dolan R. New York: Churchill Livingstone; 1995:2455-2475.
21. Luft B, Remington JS: Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992, 15:211-222.
22. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 35 (suppl 1S):3S-15S.
23. Wong S-Y, Remington JS: Biology of Toxoplasma gondii. AIDS 1993, 7:299-316.
24. Farizo KM, Buehler JW, Chamberland ME, et al.: Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992, 267:1798-1805.
25. SAS Institute: SAS language: PC version 6.1. Cary: SAS Institute; 1990.
26. Cox DR, Oaks D: Analysis of Survival Data. London: Chapman and Hall; 1984.
27. McCullagh P, Nelder JA: Generalized Linear Models, 2nd Edn. New York: Chapman and Hall; 1989.
28. Lawless JE: Statistical Models and Methods for Lifetime Data. New York: John Wiley and Sons, Inc.; 1982.
29. Jacobson MA, Besch CL, Child C, et al.: Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. J Infect Dis 1994, 169:384-394.
30. Wilson M, Lewis B, Fried J, et al.: Seroepidemiology of toxoplasmosis in the United States. 94th General Meeting of the American Society of Microbiology. Las Vegas, May 1994 [abstract C545].
31. Tirard V, Niel G, Rosenheim M, et al.: Diagnosis of toxoplasmosis in patients with AIDS by isolation of the parasite from the blood [letter]. N Engl J Med 1991, 324:634.
32. Hanson DL, Chu SY, Farizo KM, Ward JW: Distribution of CD4+ T-lymphocytes at diagnosis of AIDS-defining and other human immunodeficiency virus-related illnesses. Arch Intern Med 1995, 155:1537-1542.
33. Bozzette SA, Finkelstein DM, Spector SA, et al.: A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995, 322:693-699.